Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
Kongyong CuiShu-Zheng LyuHong LiuXiantao SongFei YuanFeng XuMin ZhangWei WangMingduo ZhangDongfeng ZhangJinfan TianPublished in: Cardiovascular diabetology (2019)
In patients with STEMI and multivessel disease, diabetes is not an independent predictor of adverse cardiovascular events at 5 years. In nondiabetic patients, an approach of staged complete revascularization is superior to culprit-only PCI, whereas the advantage of staged PCI is attenuated in diabetic patients. Trial registration This study was not registered in an open access database.
Keyphrases
- percutaneous coronary intervention
- st segment elevation myocardial infarction
- coronary artery disease
- cardiovascular events
- st elevation myocardial infarction
- coronary artery bypass grafting
- acute myocardial infarction
- antiplatelet therapy
- acute coronary syndrome
- cardiovascular disease
- type diabetes
- coronary artery bypass
- ejection fraction
- end stage renal disease
- glycemic control
- atrial fibrillation
- study protocol
- newly diagnosed
- prognostic factors
- clinical trial
- emergency department
- chronic kidney disease
- phase ii
- drug induced
- adverse drug